In this episode in our Diabetes Technology Starts series, Lucas Schuster, founder and CEO of Syntactiq, unpacks the gap between what diabetes technology can measure and what research teams can realistically use day to day. We talk about collecting richer contextual data, enabling donation for research, and supporting partners who need to analyze their own sensitive health data, from continuous glucose monitoring logs to EHR datasets, omics data, and clinical trial data.

In the third episode of our Diabetes Technology Starts series, we talk with John Sjolund, co-founder of Luna Diabetes, about bringing nighttime automated insulin delivery to people who use pens, focusing on better mornings, fewer alarms, and simpler tech. We cover evidence so far, algorithm design, travel, Type 2 potential, cost, and environmental impact.

In this second episode of our Diabetes Technology Starts series, we speak with Sweet Spot co-founder and physician Amiad Fredman about turning continuous glucose monitoring (CGM) data into proactive diabetes care. He explains how Sweet Spot partners with endocrinology and primary care practices to remotely monitor patients using tools like the Glycemia Risk Index (GRI) to triage risk and guide timely insulin adjustments between visits without requiring new devices or added work from patients. We also discuss the role of AI in analyzing glucose data and streamlining clinical workflows, as well as Sweet Spot’s provider-aligned business model that supports sustainable remote monitoring.